TU
BIO icon

TDAM USA’s Bio-Rad Laboratories Class A BIO Stock Holding History

TDAM USA’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,314
Closed -$305K – 247
2018
Q4 		$305K Sell
1,314
-122
-8% -$32.7K 0.02% 271
2018
Q3 		$449K Sell
1,436
-942
-40% -$292K 0.03% 264
2018
Q2 		$686K Sell
2,378
-6,358
-73% -$1.76M 0.04% 236
2018
Q1 		$2.19M Sell
8,736
-1,802
-17% -$459K 0.13% 122
2017
Q4 		$2.52M Sell
10,538
-962
-8% -$233K 0.14% 112
2017
Q3 		$2.56M Buy
11,500
+999
+10% +$225K 0.15% 113
2017
Q2 		$2.38M Sell
10,501
-598
-5% -$130K 0.12% 126
2017
Q1 		$2.21M Buy
11,099
+198
+2% +$38.1K 0.11% 134
2016
Q4 		$1.99M Buy
10,901
+52
+0.5% +$8.87K 0.1% 137
2016
Q3 		$1.78M Sell
10,849
-212
-2% -$32.2K 0.09% 158
2016
Q2 		$1.58M Sell
11,061
-1,083
-9% -$154K 0.08% 163
2016
Q1 		$1.66M Buy
12,144
+1,144
+10% +$150K 0.08% 166
2015
Q4 		$1.52M Buy
11,000
+994
+10% +$138K 0.07% 171
2015
Q3 		$1.34M Buy
10,006
+1,856
+23% +$267K 0.07% 183
2015
Q2 		$1.23M Sell
8,150
-189
-2% -$27K 0.06% 212
2015
Q1 		$1.13M Buy
+8,339
New +$1.03M 0.05% 238

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TDAM USA's BIO Position: Q1 2019 in Review

TDAM USA sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2019, closing a stake of 1,314 shares — an estimated $305K sold.

TDAM USA first reported a position in BIO in Q1 2015 and held it in 16 quarters. The position peaked at $2.56M in Q3 2017. 347 funds tracked by Wall St. Rank hold BIO as of Q1 2019.

  • TDAM USA reported no remaining Bio-Rad Laboratories Class A position as of Q1 2019 after selling out during the quarter.
  • TDAM USA sold 1,314 Bio-Rad Laboratories Class A shares in Q1 2019, an estimated $305K.
  • TDAM USA first reported a position in Bio-Rad Laboratories Class A in Q1 2015 and held it in 16 quarters.
  • TDAM USA's Bio-Rad Laboratories Class A position peaked at $2.56M in Q3 2017.
  • 347 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2019.

Based on TDAM USA's 13F filing for Q1 2019, filed 8 May 2019.